arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Akari Therapeutics Plc

AKTX

$7.72 ▲ +0.28 (+3.76%) at close

22 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Akari Therapeutics Plc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $519.8B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -57.6% ↗

FCF / Share $-0.00 ↗

Trailing P/E —

Price / Book 24673.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

22-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-17.30M

↑ +12.6% —

FCF / Share Free cash flow per share

$-0.00

↑ +70.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
EPS Growth YoY (%)	—	—	—	—	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	12.6% Fair ↑ Fair Improving Year-over-year change in net income	-97.8% Weak ↓ Weak Declining Year-over-year change in net income	43.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.9% Weak → Weak Stable Year-over-year change in net income	-2.0% Weak ↓ Weak Declining Year-over-year change in net income	0.1% Caution ↑ Caution Improving Year-over-year change in net income	-3.9% Weak ↓ Weak Declining Year-over-year change in net income	53.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-95.1% Weak ↑ Weak Improving Year-over-year change in net income	60.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-2226.9% Weak ↓ Weak Declining Year-over-year change in net income	46.2% Excellent ↑ Excellent Improving Year-over-year change in net income	15.2% Good ↑ Good Improving Year-over-year change in net income	-101.4% Weak ↓ Weak Declining Year-over-year change in net income	-213.9% Weak ↓ Weak Declining Year-over-year change in net income	33.3% Excellent ↑ Excellent Improving Year-over-year change in net income	29.5% Excellent ↑ Excellent Improving Year-over-year change in net income	54.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-77.0% Weak Weak Year-over-year change in net income	28.6% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	70.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	68.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	51.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	21.6% Good ↓ Good Declining Year-over-year change in free cash flow	18.2% Good ↓ Good Declining Year-over-year change in free cash flow	23.9% Good → Good Stable Year-over-year change in free cash flow	51.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	42.2% Excellent Excellent Year-over-year change in free cash flow	-21.0% Weak Weak Year-over-year change in free cash flow	—	—	93.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Effective Tax Rate (%) (%)	5.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.64x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.36x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Return on Invested Capital (%)	-57.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-97.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7338.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1289.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-309.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-191.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	957.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-642.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-220.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-79.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	86.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	71.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-36.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-385.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-166.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-147.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-123.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-249.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-249.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-130.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-327.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-61.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-507%)	-89.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-694%)	—	—	—	-182.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1313%)	—	—	-206.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1476%)	-53.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	-93.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-720%)	-87.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-684%)	-62.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-515%)	127.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+747%)	85.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+468%)	33.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+125%)	59.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+297%)	114.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+660%)	—	—	-201.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1440%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Interest Coverage (x)	-172.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-151.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	-10.01x Weak Weak Operating income divided by interest expense Optimal: > 5x	-353.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$0.00	$-2.60M	$-3.85M	$-13.25M	$-9.36M	$-14.06M	$-5.73M	$-5.45M	$-28.11M	$-34.10M	$-68.92M	$-3.33M	$-7.66M	$-1.10M	$-6.00K	$-9.00K	—	—	—	—	—	$0.00

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Basic EPS, GAAP (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	$-0.00	$-0.00	$-0.00	$-0.00	$-0.01	$-0.01	$-0.01	$-0.03	$-0.02	—	$-0.02	$-0.26	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.00	$0.00	$-0.00	$0.00	$0.00	$0.00	$-0.00	$0.00	$0.01	$0.03	$0.04	$0.00	$0.14	$-0.25	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.00	$0.00	$-0.00	$0.00	$0.00	$0.00	$-0.00	$0.00	$0.01	$0.03	$0.02	$0.00	$0.14	$-0.25	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	67.33B	23.89B	9.79B	6.24B	4.29B	3.16B	1.83B	1.54B	1.25B	1.18B	852.09M	85.52M	21.08M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Working Capital (USD)	$-6.89M	$-16.96M	$-243.00K	—	—	—	—	$2.54M	$16.96M	$33.92M	$48.53M	$2.16M	$6.60M	$-2.73M	—	—	—	—	—	—	—	—
Total Equity (USD)	$28.33M	$22.23M	$-229.00K	$1.79M	$5.55M	$9.38M	$-1.77M	$3.11M	$17.15M	$34.10M	$48.72M	$2.22M	$5.81M	$-3.36M	$-2.48M	$-2.00M	$-1.70M	$-1.26M	$-60.00K	$-467.00K	$1.23M	$0.00

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗	FY 2017 Dec 31, 2017 20-F ↗	FY 2016 Dec 31, 2016 20-F ↗	FY 2015 Dec 31, 2015 20-F ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 20-F ↗	FY 2011 Dec 31, 2011 20-F ↗	FY 2010 Dec 31, 2010 20-F ↗	FY 2009 Dec 31, 2009 20-F ↗	FY 2008 Dec 31, 2008 20-F ↗	FY 2007 Dec 31, 2007 20-F ↗	FY 2006 Dec 31, 2006 20-F ↗	FY 2005 Dec 31, 2005 20-F ↗	FY 2004 Oct 6, 2004 20-F ↗
Depreciation Expense (USD)	—	$14.00K	$4.00K	$3.71K	$4.13K	$8.91K	$19.20K	$35.85K	$42.40K	$39.94K	$10.16K	$4.94K	$2.00K	$2.00K	$0.00	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-17.30M	$-19.79M	$-10.01M	$-17.75M	$-17.42M	$-17.08M	$-17.11M	$-16.47M	$-35.40M	$-18.14M	$-45.32M	$-1.95M	$-3.62M	$-4.27M	$-2.12M	$-675.00K	$-1.01M	$-1.44M	$-3.13M	$-1.77M	$-2.48M	—
Operating Cash Flow (USD)	$-10.57M	$-12.55M	$-16.43M	$-21.50M	$-18.85M	$-16.95M	$-12.92M	$-22.58M	$-31.60M	$-24.62M	—	$-1.48M	$-5.45M	$-2.13M	$-1.01M	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 22 years · 39 quarters

Akari Therapeutics Plc

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AKTX with peers